Direct Link:
1365-2036/asset/olbannerleft.gif?v=1&s=45db8c78d1d41c404034f2eaf7587620d5727843)
1365-2036/asset/olbannerright.gif?v=1&s=45518840b7e2e59fcc9d74113b13f4474a604878)
You have full text access to this OnlineOpen article
Review article: hepatitis B and liver transplantation
Article first published online: 30 MAR 2006
DOI: 10.1111/j.1365-2036.2006.02855.x
Additional Information
How to Cite
MUTIMER, D. (2006), Review article: hepatitis B and liver transplantation. Alimentary Pharmacology & Therapeutics, 23: 1031–1041. doi: 10.1111/j.1365-2036.2006.02855.x
Publication History
- Issue published online: 30 MAR 2006
- Article first published online: 30 MAR 2006
- Publication data Submitted 10 January 2006 First decision 20 January 2006 Resubmitted 24 January 2006 Accepted 25 January 2006
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection, Transplant Infectious Disease, 2013, 15, 2
- 2, , , , , , , , , , , Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation, Liver Transplantation, 2013, 19, 5Direct Link:
- 3, , Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B, International Journal of Infectious Diseases, 2012, 16, 3, e152
- 4, , , , , , Efficacy and Safety of Entecavir and/or Tenofovir for Prophylaxis and Treatment of Hepatitis B Recurrence Post–Liver Transplant, Transplantation Proceedings, 2010, 42, 8, 3167
- 5, , , , , , , , Efficacy, safety, and pharmacokinetics of intramuscular hepatitis B immune globulin, Igantibe®, for the prophylaxis of viral B hepatitis after liver transplantation, Digestive and Liver Disease, 2010, 42, 7, 509
- 6, Hepatitis B after transplantation: Competition between the recipient virus and the donor virus, Liver Transplantation, 2010, 16, 11Direct Link:
- 7, , Management of End-Stage Liver Disease in Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 477
- 8, , , , The role of anti-core antibody response in the detection of occult hepatitis B virus infection, Clinical Chemistry and Laboratory Medicine, 2010, 48, 1
- 9, , , , , , , Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation, Transplantation Proceedings, 2009, 41, 10, 4253
- 10, , , , Pharmacokinetics of intramuscular and intravenous HBIG: Which implications for practice?, Digestive and Liver Disease Supplements, 2009, 3, 4, 119
- 11, , , , , , , , , Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine, Journal of Hepatology, 2008, 48, 4, 540
- 12, , Chronic hepatitis B, Hepatology, 2007, 45, 2Direct Link:
- 13, , , , , , , Combination Therapy in Liver Transplant Recipients with Hepatitis B Virus Without Hepatitis B Immune Globulin, Digestive Diseases and Sciences, 2007, 52, 10, 2497
- 14, Current concepts in the evaluation of patients for liver transplantation, Expert Review of Gastroenterology & Hepatology, 2007, 1, 2, 307
- 15, , , , , , , , , Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation, Liver Transplantation, 2007, 13, 3Direct Link:
- 16, , Treatment of Viral Hepatitis in Children, Archives of Medical Research, 2007, 38, 6, 702
- 17, , The Acute Liver Failure Patient,Direct Link:
- 18, , The Liver Transplant Recipient,Direct Link: